MULTIMERIC POLYPEPTIDES AND USES THEREOF

Binding Domains Directed Against GPCR:G Protein Complexes and Uses Derived Thereof

CELLS EXPRESSING UMAMI TASTE RECEPTORS AND USES THEREOF

CELLS EXPRESSING BITTER TASTE RECEPTORS AND USES THEREOF

Albumin Bound Macromolecule Tri-Agonist Activating GLP-1/GIP/Glucagon Receptors

Albumin Bound Macromolecule Tri-Agonist Activating GLP 1/GIP/Glucagon Receptors And Methods Therefor

COMPOSITIONS, KITS AND METHODS FOR TREATMENT OF COMPLEMENT-RELATED DISORDERS

Treatment of nerve damage using 5'UTR of Gpr151 gene or variant thereof

ANTIBODY DRUG CONJUGATES AND METHODS FOR MAKING THEREOF

CELL-DERIVED VESICLES COMPRISING TARGET PROTEIN AND METHOD FOR PRODUCING SAME

PHOTORESPONSIVE PROTEIN FOR COLOR RECOGNITION AND USE THEREOF

VACCINE VECTOR ENCODING MUTATED GNAQ FOR TREATMENT OF UVEAL MELANOMA AND CANCERS HAVING ONCOGENIC MUTATIONS ON GNAQ AND GNA11 PROTEINS

Peptides and nanoparticle formulations thereof

Method of treating hypercytokinemia by administering the CCR5/CCL5 (RANTES) interaction inhibitor maraviroc

HELIX-GRAFTED PROTEINS AS INHIBITORS OF DISEASE-RELEVANT PROTEIN-PROTEIN INTERACTIONS

Inhibitors of β integrin-G protein α subunit binding interactions

Method of treating COVID-19 by administering the CCR5/CCL5 (RANTES) interaction inhibitor maraviroc

Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

CONSTRUCT FOR EXPRESSING G PROTEIN-COUPLED RECEPTOR OR SUBUNIT THEREOF, AND USE OF SAID CONSTRUCT

Binding domains directed against GPCR:G protein complexes and uses derived thereof

G proteins

Helix-grafted proteins as inhibitors of disease-relevant protein-protein interactions

G proteins

Inhibitors of beta integrin-G protein alpha subunit binding interactions

Inhibitors of mitochondrial fission and methods of use thereof

CHIMERIC VSV-G PROTEINS AS NUCLEIC ACID TRANSFER VEHICLES

Inhibitors of mitochondrial fission and methods of use thereof

Human G protein alpha subunit gail with at least one mutated amino acid residue

Binding domains directed against GPCR:G protein complexes and uses derived thereof

Biosensor based on Gβγ-interacting proteins to monitor G-protein activation

Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormone

Inhibitors of beta integrin-G protein alpha subunit binding interactions

Helix-grafted proteins as inhibitors of disease-relevant protein-protein interactions

Inhibitors of mitochondrial fission and methods of use thereof

Method of inhibiting angiogenesis using inhibitors of G-protein-coupled receptor kinase interacting protein-1 (GIT1)

Chimeric VSV-G proteins as nucleic acid transfer vehicles

Compositions and methods for increasing the expression and signalling of proteins on cell surfaces

Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors

Methods and G proteins for screening and identifying ligands of G protein-coupled receptors

Binding domains directed against GPCR:G protein complexes and uses derived thereof

Inhibitors of mitochondrial fission and methods of use thereof

Inhibitors of beta integrin-G protein alpha subunit binding interactions

MUTANT G-PROTEIN COUPLED RECEPTOR PROTEINS AND METHODS FOR PRODUCING THEM

CANCER GENE THERAPY USING NUCLEIC ACIDS ENCODING US28 AND G-PROTEIN

Aqueous Solution Containing Partial Ras Polypeptide and Method for Screening Inhibitor of Ras Function

Inhibitors of beta integrin-G protein alpha subunit binding interactions

Inhibitors of mitochondrial fission and methods of use thereof

Chimeric Polypeptides Useful in Proximal and Dynamic High-Throughput Screening Methods

GFP FUSION PROTEINS AND THEIR USE

GQ protein competitive inhibitory polypeptides, preparation methods and uses thereof

IQGAP3 EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME

G-proteins

System for the Determination of Molecules Altering the Function of Interferon, Method Therefor and Compounds Altering Interferon Activity

NOVEL ANTI-ALLERGIC AGENTS

Antibody Recognizing G Protein, and Agent and Kit Using the Same

Anti-Allergic Complex Molecules

ATLASTIN

sphingosine 1-phosphate receptor isoform 1

Resistance Genes

AGENTS FOR PROPHYLAXIS OR TREATMENT OF NEUROLOGICAL RELATED DISEASES AND CONDITIONS

Materials and methods relating to G-protein coupled receptor oligomers

G protein coupled receptor signaling modulation

YEAST CELLS EXPRESSING MODIFIED G PROTEINS AND METHODS OF USE THEREFOR

Protein involved in G protein-coupled receptor mediated signal transduction with ability to mediate signal transduction from a dopamine D1 receptor or an adenosine A2A receptor to an adenylate cyclase and utilization thereof

Transgenic animal

Gnal Splice Variant and Uses Thereof

Gm1 promoter and use thereof

Materials and methods relating to G-protein coupled receptor oligomers

Method for identifying modulators of G protein coupled receptor signaling

Novel compositions and methods for lymphoma and leukemia

Atlastin

Anti-allergic complex molecules

Diagnostic and therapeutic use of a rab family gtp-binding protein for neurodegenerative diseases

G-proteins

GFP fusion proteins and their use

Anti-allergic complex molecules

Galphaq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors

Atlastin

Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics

G proteins, polynucleotide encoding the same and utilization thereof

Expression of G protein coupled receptors in yeast

Yeast cells expressing modified G proteins and methods of use therefor

Biosensor and use thereof to identify therapeutic drug molecules and molecules binding orphan receptors

Solid phase isolation of proteins, nucleic acids and other macromolecules

Tumour associated antigens

Gαprotein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors

Chimeric Galpha 15 variants and their use in the analysis and discovery of modulators of G-protein coupled receptors

Novel promiscuous G alpha protein mutants and their use

Chimeric Gatiphal 15 variants and their use in the analysis and discovery of modulators of G-protein coupled receptors